FellowshipJoin ARTIS Ventures' TechBio Fellows for a unique opportunity in healthcare and life sciences.

ARTIS Ventures is a San Francisco-based venture capital firm specializing in early-stage investments at the intersection of technology and biology, known for coining the term 'TechBio'.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Third-party rankings
| Ranking | Edition | Listed as | Position | Since last edition | Trust | What it measures |
|---|---|---|---|---|---|---|
| Strebulaev-Jackson Venture Ranking: Top 50 Biotech VC Firms | 2026 | ARTIS | #37 | No prior edition | B | Performance |
Founded in 2001, ARTIS Ventures is a venture capital firm based in San Francisco, California. The firm focuses on supporting visionary founders innovating in critical technologies that enhance human health and resilience. ARTIS Ventures coined the term 'TechBio' to describe its investment strategy, which targets essential systems affecting global health, infrastructure, and security, with a strong emphasis on artificial intelligence and engineered technologies. The firm aims to accelerate the deployment of critical innovations that can improve health outcomes and societal resilience. Notable portfolio companies include YouTube, Palantir, and Stemcentrx.
ARTIS Ventures invests in startups that leverage technology to transform human health. Their investment strategy is centered around critical innovations in artificial intelligence and engineered technologies, aiming to accelerate the deployment of solutions that enhance health outcomes and societal resilience.
ARTIS Ventures provides significant value to its portfolio companies through its in-house scientific expertise, leveraging the TechBio Fellows Program to embed MDs and PhDs within the investment team. This structure supports rigorous due diligence and ongoing assistance to portfolio companies, enhancing their growth and innovation potential.
ARTIS Ventures focuses on startups that leverage technology to enhance human health and resilience. They invest in sectors such as AI, healthcare, biotech, fintech, and consumer products, targeting companies at seed, Series A, Series B, and growth equity stages.
Founders can pitch to ARTIS Ventures through their website at av.co. It is recommended to include a clear description of the technology, market opportunity, and team in the pitch deck.
ARTIS Ventures is distinguished by its focus on the TechBio sector, a term they coined to describe the intersection of technology and biology. They provide in-house scientific expertise through their TechBio Fellows Program, embedding MDs and PhDs within their investment team.
ARTIS Ventures typically writes checks ranging from $2 million to $15 million, depending on the stage of the company and the specific investment opportunity.
The firm primarily invests in startups based in North America, aligning with their mission to enhance global health and resilience.
ARTIS Ventures provides significant value to its portfolio companies through rigorous due diligence, ongoing assistance, and access to their network of experts in the TechBio field.
Superscout Pro
Is this page right?Reviewed · How the research works